In Vitro Activity of Ceftolozane/Tazobactam and Imipenem/Relebactam against Pseudomonas aeruginosa from Patients in the United States - SMART 2017-2018

Presenter
  • M. Hackel
Session
Virtual 317 - AAR02 In Vitro Antimicrobial Surveillance - Focus on Gram-negatives

Previous ePoster
High Prevalence of Colistin Resistance in Community Acquired Uro-Pathogens from a Large Tertiary Care Centre of India

Next ePoster
Evaluation of the Hypermucoviscous Phenotype in the Pathogenicity of an K64 Xdr Klebsiella Pneumoniae Strains Causing Bacteraemia
Developing a Time Lapse Native/sds-page System to Monitor Protein Changes During Autolysis of L. Reuteri Cells
Characterizing the Phenotypic Transition of Pseudomonas Aeruginosa from the Hospital Environment to Nosocomial Infections
Determination of the Minimum Inhibitory Concentrations (MIC) and Minimum Bactericidal Concentrations (MBC) of Five Antiseptic Active Ingredients against Strains of 25 Species of Medically Relevant Bacteria and Yeast
Bacteriological and Physicochemical Analyses of Well Water Used for Drinking In Ekpoma-edo State, Nigeria
Residue R250 is Critical for Substrate and Inhibitor Recognition in the OXA-48 Carbapenemase
Identification of Antibiotic Resistant Bioprospects Present in Metagenomic Libraries from the Sub Tropical Dry Forest Reserve in Puerto Rico
Exploring Metagenomic Assembly Graphs to Identify Novel Microbial Variants Contributing to Human and Environmental Health
Resistance-guided Isolation of Streptomyces sp. from River Sediments and Investigation of their Antibacterial Activities
High Antibiotic Resistance among Pseudomonas aeruginosa in a Tertiary Care Nepalese Hospital